Fort Washington, PA USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

NCCN Foundation® Appoints Three New Representatives to Board of Directors


The NCCN Foundation welcomes Heather Kopecky, PhD, MBA; Marc Samuels, JD, MPH; and Susan Stein, MPH, as the newest representatives to its Board of Directors.
20-Nov-2015 3:00 PM EST Add to Favorites

Dr. Robert C. Young Joins NCCN Leadership Team


Robert C. Young, MD, has been appointed Interim Vice President of the NCCN Oncology Research Program (ORP).
16-Nov-2015 12:30 PM EST Add to Favorites

NCCN Unveils Evidence Blocks for CML and Multiple Myeloma

New visual tool illustrates five dimensions of value within NCCN Guidelines
16-Oct-2015 3:10 PM EDT Add to Favorites

NCCN to Unveil Oncology Value Tool at Oct 16 Press Conference in San Francisco

Press Conference and Media Panel: NCCN Guidelines with NCCN Evidence Blocks: A View of the Patient-Empowered Cancer Conversation
7-Oct-2015 10:20 AM EDT Add to Favorites

NCCN Publishes New Patient Education Resources for Kidney Cancer

NCCN has published the NCCN Guidelines for Patients® and NCCN Quick Guide™ for Kidney Cancer, the newest addition to the library of NCCN Guidelines for Patients.
25-Aug-2015 2:10 PM EDT Add to Favorites

NCCN Seeking Poster Presentations from Nation’s Top Oncology Researchers

NCCN is now accepting original abstracts from investigators for consideration for the NCCN 21st Annual Conference General Poster Session; the deadline for submissions is Friday, November 6, 2015.
3-Aug-2015 10:15 AM EDT Add to Favorites

NCCN Receives $2 Million in Research Funding from Boehringer Ingelheim to Study Targeted Combination Approaches with Afatinib in Lung Cancer

The NCCN Oncology Research Program (ORP) received a $2-million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to facilitate studies of afatinib in non-small cell lung cancer.
11-Jun-2015 9:35 AM EDT Add to Favorites

NCCN Collaborates with Pfizer to Improve Provider Performance and Quality in Treatment of Metastatic Breast Cancer

NCCN and Pfizer will elicit grant proposals for quality improvement and education in metastatic breast cancer.
2-Jun-2015 1:15 PM EDT Add to Favorites

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos